Home › Multiple Sclerosis › North Carolina
Multiple Sclerosis clinical trials in North Carolina
9 studies for Multiple Sclerosis are looking for participants at sites in North Carolina.
Cities in North Carolina
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 10, 2026 · NCT07002034A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Local Institution - Site 101, Raleigh
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Oct 30, 2026 · NCT07840326A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Charlotte
- TG Therapeutics Investigational Trial Site, New Bern
- TG Therapeutics Investigational Trial Site, Raleigh
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT06433752A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
- BRIUMVI® Pregnancy Registry Virtual Research Coordination Center, Wilmington
RecruitingObservational study
Ages 15 to 50 · Women · Updated Oct 29, 2026 · NCT06433765Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Piedmont HealthCare - Lake Norman Neurology- Site Number : 8400002, Charlotte
- Raleigh Neurology Associates- Site Number : 8400014, Raleigh
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Oct 13, 2026 · NCT07325292A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Atrium Health, Charlotte
- Velocity Clinical Research, Raleigh
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Oct 13, 2026 · NCT07225504Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- Duke University, Durham
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT07477639Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- IQVIA US Office, Durham
RecruitingObservational study
All ages · Women · Updated Aug 11, 2026 · NCT05658497Retinal Imaging in Neurodegenerative Disease
- Duke University Medical Center, Durham
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 4, 2026 · NCT03233646From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.